Company: THC
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000070318-25-000009
Chunk: 120

Company: TENET HEALTHCARE CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 120
---
 no longer satisfied.

Costs Associated with Exit or Disposal ActivitiesWe recognize costs associated with exit (including restructuring) or disposal activities when they are incurred and can be measured at fair value, rather than at the date of a commitment to an exit or disposal plan. Our restructuring plans typically focus on the alignment of our operations in the most strategic and cost‑effective structure, such as the establishment of support operations at our GBC, among other things. Certain restructuring and acquisition‑related costs are based on estimates. Changes in estimates are recognized as they occur.

NOTE 2. EQUITY

Nonredeemable Noncontrolling InterestsThe table below presents our nonredeemable noncontrolling interests balances by segment:December 31,20242023Hospital Operations$205 $185 Ambulatory Care1,444 1,324 Total nonredeemable noncontrolling interests$1,649 $1,509 Our net income attributable to nonredeemable noncontrolling interests by segment are presented in the table below:Years Ended December 31,202420232022Hospital Operations$50 $30 $21 Ambulatory Care341 304 221 Total net income available to noncontrolling interests$391 $334 $242 

86

Table of Contents

2022 Share Repurchase ProgramIn October 2022, our board of directors authorized the repurchase of up to $1.000 billion of our common stock through a share repurchase program (the “2022 share repurchase program”). This program allowed for share repurchases to be made in open‑market or privately negotiated transactions, at management’s discretion subject to market conditions and other factors, and in a manner consistent with applicable securities laws and regulations. The program did not require us to acquire any particular amount of common stock and could be suspended for periods or discontinued at any time. We did not make further repurchases under the 2022 share repurchase program following our board of directors’ approval of a new share repurchase program (discussed below), and it expired on December 31, 2024.The following table presents transactions completed under the 2022 share repurchase program during the periods shown:PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced ProgramMaximum Dollar Value of Shares That May Yet be Purchased Under the Program (In Thousands)(In Thousands)(In Millions)Inception through October 31, 202